Search

Search Constraints

You searched for: Author/Creator Pariser, D.M.

Search Results

1. Apremilast for the treatment of moderate‐to‐severe palmoplantar psoriasis: results from a double‐blind, placebo‐controlled, randomized study. (15th November 2017)

2. Drug survival of biologic therapy in a large, disease‐based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (30th March 2016)

3. Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study. (1st July 2018)

4. Efficacy and safety of the Janus kinase 1 inhibitor PF‐04965842 in patients with moderate‐to‐severe psoriasis: phase II, randomized, double‐blind, placebo‐controlled study. (6th March 2018)

5. Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version. (14th September 2015)

8. Photodynamic therapy with methyl aminolaevulinate 80 mg g−1 for severe facial acne vulgaris: a randomized vehicle‐controlled study. (1st April 2016)

9. Photodynamic therapy with methyl aminolaevulinate 80 mg g−1 for severe facial acne vulgaris: a randomized vehicle‐controlled study4. (28th February 2016)